ClinConnect ClinConnect Logo
Search / Trial NCT01459406

Effects of FODMAPs on Small Bowel Water Content: an MRI Study

Launched by UNIVERSITY OF NOTTINGHAM · Oct 24, 2011

Trial Information

Current as of June 03, 2025

Completed

Keywords

Gastrointestinal Physiology Gastrointestinal Response To Sugars Mri Gastrointestinal Stomach Small Bowel Colon Glucose Fructose Fructan Fodmap

ClinConnect Summary

Title: Effects of FODMAPs (Fermentable Oligo-, Di-, and Mono-saccharides, And Polyols) on small bowel water content: an MRI study

1. Background. FODMAPs consist of fructose, lactose, fructo- and galacto-oligosaccharides such as fructans and galactans, and polyols such as sorbitol and mannitol. These carbohydrates are poorly absorbed in the small intestine and have been shown to trigger symptoms of irritable bowel syndrome (IBS). Previous studies have shown that fructose malabsorption results in an increased osmotic load in the small bowel, which can have a laxative effect. Physical proof o...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Apparently healthy: no medical conditions which might effect study measurements.
  • No reported participation in another nutritional or biomedical trial 3 months before the pre-study examination or during the study.
  • Age ≥ 18 and ≤ 60 year at pre-study investigation.
  • Body mass index (BMI) ≥ 18.0 and ≤ 30.0 kg/m2
  • No reported participation in night shift work two days prior to pre-study investigation or during the study. Night work is defined as working between midnight and 6.00 AM.
  • Strenuous exercise ≤ 10 hours per week.
  • Gender: male or female
  • Consumption of ≤ 21 alcoholic drinks in a typical week
  • Currently not smoking
  • Suitable for MRI scanning (e.g., absence of metal implants, infusion pumps and pacemakers) as assessed by the attached MRI safety questionnaire.
  • Exclusion Criteria:
  • - use of medication which interferes with study measurements or bowel motility (as judged by the study physician).
  • Antibiotics in the 3 weeks before pre-study examination
  • Probiotics or during the study

About University Of Nottingham

The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.

Locations

Nottingham, Nottinghamshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

Robin C Spiller, MD FRCP

Principal Investigator

University of Nottingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials